Home › Immunoblastic Lymphadenopathy › Minnesota
Immunoblastic Lymphadenopathy clinical trials in Minnesota
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in Minnesota.
Cities in Minnesota
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Essentia Health Cancer Center, Duluth
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
- Mayo Clinic (Data Collection Only), Rochester
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.